Published in Mol Genet Metab on June 28, 2013
Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am J Hum Genet (2014) 1.73
Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord (2014) 1.40
The challenge and promise of glycomics. Chem Biol (2014) 1.13
Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Glycobiology (2015) 1.06
Genetic defects in dolichol metabolism. J Inherit Metab Dis (2014) 0.86
Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression. Sci Rep (2015) 0.83
Severe, fatal multisystem manifestations in a patient with dolichol kinase-congenital disorder of glycosylation. Mol Genet Metab (2013) 0.79
A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations. Neuromuscul Disord (2014) 0.78
Prenatal muscle development in a mouse model for the secondary dystroglycanopathies. Skelet Muscle (2016) 0.77
Fluorescence detection in automated DNA sequence analysis. Nature (1986) 12.53
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33
Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides. Hum Mutat (2009) 2.03
Congenital disorders of glycosylation. Ann N Y Acad Sci (2010) 1.93
Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science (2013) 1.91
Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. Am J Hum Genet (2009) 1.83
The ins(ide) and out(side) of dolichyl phosphate biosynthesis and recycling in the endoplasmic reticulum. Glycobiology (2001) 1.63
Human dolichol-phosphate-mannose synthase consists of three subunits, DPM1, DPM2 and DPM3. EMBO J (2000) 1.43
Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin Chem (2001) 1.38
Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie) J Clin Invest (2000) 1.36
Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation. PLoS Genet (2011) 1.36
Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. J Clin Invest (2000) 1.33
Glycomic analyses of mouse models of congenital muscular dystrophy. J Biol Chem (2011) 1.32
DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy. Ann Neurol (2012) 1.29
How to find and diagnose a CDG due to defective N-glycosylation. J Inherit Metab Dis (2011) 1.18
The ever-expanding spectrum of congenital muscular dystrophies. Ann Neurol (2012) 1.15
Cell-matrix interactions in muscle disease. J Pathol (2012) 1.12
DPM1, the catalytic subunit of dolichol-phosphate mannose synthase, is tethered to and stabilized on the endoplasmic reticulum membrane by DPM3. J Biol Chem (2005) 0.94
Lipid intermediates involved in the assembly of membrane-associated glycoproteins in calf brain white matter. Arch Biochem Biophys (1976) 0.93
Nijmegen paediatric CDG rating scale: a novel tool to assess disease progression. J Inherit Metab Dis (2011) 0.92
Congenital disorder of glycosylation (CDG) type Ie. A new patient. J Inherit Metab Dis (2004) 0.90
Stimulation by dolichol phosphate-mannose and phospholipids of the biosynthesis of N-acetylglucosaminylpyrophosphoryl dolichol. J Biol Chem (1985) 0.88
A new intronic mutation in the DPM1 gene is associated with a milder form of CDG Ie in two French siblings. Pediatr Res (2006) 0.84